Literature DB >> 27891406

Amniotic Fluid Embolism with Isolated Coagulopathy: A Report of Two Cases.

Chi-Yuan Liao1, Fuh-Jinn Luo2.   

Abstract

Amniotic Fluid Embolism (AFE) is a catastrophic complication of pregnancy with high mortality rate. The most common clinical presentation is an abrupt onset of cardiopulmonary collapse. Here, we present an uncommon variant involving isolated disseminated intravascular coagulation that developed without antecedent cardiopulmonary disturbances. Both patients developed symptoms soon after delivery. Blood test was sent at 14 minutes postpartum for the second patient due to suspected amniotic fluid embolism. Fetal components were observed in the uterine veins of the lower uterine segments in both cases. Amniotic fluid embolism with disseminated intravascular coagulopathy typically progresses faster than disseminated intravascular coagulopathy associated with other causes and symptoms. It usually develops within two hours of delivery. Prompt recognition and treatment of this entity is crucial to survival.

Entities:  

Keywords:  Disseminated intravascular coagulopathy; Fetal components; Maternal death; Postpartum haemorrhage

Year:  2016        PMID: 27891406      PMCID: PMC5121744          DOI: 10.7860/JCDR/2016/21720.8615

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  14 in total

Review 1.  Amniotic Fluid Embolism: Anaphylactic Reactions With Idiosyncratic Adverse Response.

Authors:  Hiroshi Kobayashi
Journal:  Obstet Gynecol Surv       Date:  2015-08       Impact factor: 2.347

2.  Squamous and trophoblastic cells in the maternal pulmonary circulation identified by invasive hemodynamic monitoring during the peripartum period.

Authors:  W Lee; K A Ginsburg; D B Cotton; R H Kaufman
Journal:  Am J Obstet Gynecol       Date:  1986-11       Impact factor: 8.661

3.  Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study.

Authors:  Michael S Kramer; Jocelyn Rouleau; Thomas F Baskett; K S Joseph
Journal:  Lancet       Date:  2006-10-21       Impact factor: 79.321

4.  Amniotic fluid embolism: decreased mortality in a population-based study.

Authors:  W M Gilbert; B Danielsen
Journal:  Obstet Gynecol       Date:  1999-06       Impact factor: 7.661

Review 5.  Amniotic fluid embolism.

Authors:  M Morgan
Journal:  Anaesthesia       Date:  1979-01       Impact factor: 6.955

6.  Acute hemodynamic and respiratory effects of amniotic fluid embolism in the pregnant goat model.

Authors:  G D Hankins; R R Snyder; S L Clark; L Schwartz; W R Patterson; C A Butzin
Journal:  Am J Obstet Gynecol       Date:  1993-04       Impact factor: 8.661

7.  Amniotic fluid embolism: analysis of the national registry.

Authors:  S L Clark; G D Hankins; D A Dudley; G A Dildy; T F Porter
Journal:  Am J Obstet Gynecol       Date:  1995-04       Impact factor: 8.661

8.  Survival after an amniotic fluid embolism following the use of sodium bicarbonate.

Authors:  Sorcha Evans; Brigid Brown; Matthew Mathieson; Stan Tay
Journal:  BMJ Case Rep       Date:  2014-05-30

9.  Amniotic fluid embolism: pathophysiology and new strategies for management.

Authors:  Naohiro Kanayama; Naoaki Tamura
Journal:  J Obstet Gynaecol Res       Date:  2014-06       Impact factor: 1.730

Review 10.  Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.

Authors:  Francesco Paolo Busardò; Paola Frati; Simona Zaami; Vittorio Fineschi
Journal:  Int J Mol Sci       Date:  2015-03-23       Impact factor: 5.923

View more
  2 in total

1.  Comparison of the Different Definition Criteria for the Diagnosis of Amniotic Fluid Embolism.

Authors:  Hiroshi Kobayashi; Juria Akasaka; Katsuhiko Naruse; Toshiyuki Sado; Taihei Tsunemi; Emiko Niiro; Kana Iwai
Journal:  J Clin Diagn Res       Date:  2017-07-01

2.  Meconium-stained amniotic fluid: a risk factor for postpartum hemorrhage.

Authors:  Carlo Bouchè; Uri Wiesenfeld; Luca Ronfani; Roberto Simeone; Paolo Bogatti; Kristina Skerk; Giuseppe Ricci
Journal:  Ther Clin Risk Manag       Date:  2018-09-11       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.